The Synthesis and Characterisation of Hydroxypropyl Cyclodextrin Inclusion Complexes in Certain Medications and Fluorophores are Compared
DOI:
https://doi.org/10.29070/5bkb8n89Keywords:
Synthesis, , Characterisation Hydroxypropyl Cyclodextrin Medications, FluorophoresAbstract
Pharmaceutical and biochemical researchers have shown great interest in the development and study of hydroxypropyl cyclodextrin (HP-β-CD) inclusion complexes because of their potential to improve the solubility, stability, and bioavailability of different drugs and fluorophores that are not very water-soluble. This research compares the methods of synthesis, efficiency of encapsulation, and physical and chemical characteristics of HP-β-CD inclusion complexes made with various drugs and fluorophores. We synthesised inclusion complexes using kneading, freeze-drying, and co-precipitation procedures. Then, we characterised them using spectroscopic methods including FTIR, NMR, and UV-Vis, as well as thermal (DSC, TGA), and crystallographic (XRD) investigations. The effective encapsulation was confirmed by the creation of inclusion complexes, which resulted in notable alterations in spectral patterns, thermal stability, and crystalline structure. Complexation with fluorophores increased photostability and fluorescence intensity, whereas medications exhibited higher water solubility and regulated release behaviour. While the inclusion method stays the same (via non-covalent contacts within the hydrophobic cavity of HP-β-CD), the comparison analysis shows that the guest molecule's structural structure and polarity determine the level of complexation and functional enhancement. These results highlight the flexible use of HP-β-CD as a host molecule in drug delivery systems and fluorescence applications, which bodes well for its potential in pharmaceutical and biomedical formulations.
References
Pinho, E., Grootveld, M., Soares, G., & Henriques, M. (2014). Cyclodextrins as encapsulation agents for plant bioactive compounds. Carbohydrate Polymers, 101, 121–135.
Szejtli, J. (1998). Introduction and general overview of cyclodextrin chemistry. Chemical Reviews, 98, 1743–1753.
Thorsteinn, L., & Robert, O. (2003). Cyclodextrins in solid dosage forms: Drug delivery oral. Business Briefing: Pharmaceutical Technology, 176–180.
Irie, T., & Uekama, K. (1997). Pharmaceutical applications of cyclodextrins: Toxicological issues and safety evaluation. Journal of Pharmaceutical Sciences, 86(2), 147–162.
Hedges, A. R. (1998). Industrial applications of cyclodextrins. Chemical Reviews, 98(5), 2035–2044.
Lu, X. N., & Chen, Y. (2002). Chiral separation of amino acids derivatized with fluorescein-5-isothiocyanate by capillary electrophoresis and laser-induced fluorescence detection using mixed selectors of β-cyclodextrin and sodium taurocholate. Journal of Chromatography A, 955(1), 133–140.
Baudin, C., Pean, C., Perly, B., & Goselin, P. (2000). Inclusion of organic pollutants in cyclodextrin and derivatives. International Journal of Environmental Analytical Chemistry, 77, 233–242.
Kumar, R., Dahiya, J. S., Singh, D., & Nigam, P. (2001). Biotransformation of cholesterol using Lactobacillus bulgaricus in a glucose-controlled bioreactor. Bioresource Technology, 78(2), 209–211.
Koukiekolo, R., Desseaux, V., Moreau, Y., Marchis, M. G., & Santimone, M. (2001). Mechanism of porcine pancreatic α-amylase: Inhibition of amylose and maltopentaose hydrolysis by α-, β-, and γ-cyclodextrins. European Journal of Biochemistry, 268(3), 841–848.
Muñoz-Botella, S., Castillo, B. D., & Martyn, M. A. (1995). Cyclodextrin properties and applications of inclusion complex formation. Ars Pharmaceutica, 36, 187–198.
Schneiderman, E., & Stalcup, A. M. (2000). Cyclodextrins: A versatile tool in separation science. Journal of Chromatography B, 745(1), 83–102.
Connors, K. A. (1997). The stability of cyclodextrin complexes in solution. Chemical Reviews, 97(5), 1325–1358.
Rao, V. M., & Stella, V. J. (2003). When can cyclodextrins be considered for solubilization purposes? Journal of Pharmaceutical Sciences, 92, 927–932.
Loftsson, T., Olafsdottir, B. J., & Frioriksdottir, H. (1993). Cyclodextrin complexation of NSAIDs: Physicochemical characteristics. European Journal of Pharmaceutical Sciences, 1, 95–101.
Uekama, K., Hirayama, F., & Irie, T. (1998). Cyclodextrin drug carrier systems. Chemical Reviews, 98(5), 2045–2076.
This work is licensed under a 